当前位置：
X-MOL 学术
›
Clin. Genitourin. Cancer
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical Profile and Outcomes of Carcinoma Penis Patients Receiving Systemic Therapy at an Indian tertiary care Center: A Retrospective Observational Study
Clinical Genitourinary Cancer ( IF 3.2 ) Pub Date : 2024-02-07 , DOI: 10.1016/j.clgc.2024.02.004 Vanita Noronha , Venkatesh Kapu , Amit Joshi , Nandini Menon , Ajay Singh , Gagan Prakash , Santosh Menon , Nilesh Sable , Vedang Murthy , Mahendra Pal , Amandeep Arora , Sravan Kumar , Shripad Banavali , Kumar Prabhash
Clinical Genitourinary Cancer ( IF 3.2 ) Pub Date : 2024-02-07 , DOI: 10.1016/j.clgc.2024.02.004 Vanita Noronha , Venkatesh Kapu , Amit Joshi , Nandini Menon , Ajay Singh , Gagan Prakash , Santosh Menon , Nilesh Sable , Vedang Murthy , Mahendra Pal , Amandeep Arora , Sravan Kumar , Shripad Banavali , Kumar Prabhash
Penile carcinoma is rare and data are scarce. Observational study at Tata Hospital (Mumbai) on 91 patients. In 19 patients treated with neoadjuvant paclitaxel + platinum, ORR=37%, surgical resection rate=31.5%. Med OS in 71 patients treated with curative intent was 33.8 months. In 20 patients treated with palliative chemotherapy, ORR-20%, mediatn OS=11.4 months
中文翻译：
在印度三级护理中心接受全身治疗的阴茎癌患者的临床概况和结果：回顾性观察研究
阴茎癌很罕见，数据也很少。塔塔医院（孟买）对 91 名患者进行的观察性研究。19例新辅助紫杉醇+铂类治疗患者中，ORR=37%，手术切除率=31.5%。71 名接受根治性治疗的患者的平均 OS 为 33.8 个月。在 20 名接受姑息化疗的患者中，ORR-20%，中位 OS=11.4 个月
更新日期：2024-02-07
中文翻译：
在印度三级护理中心接受全身治疗的阴茎癌患者的临床概况和结果：回顾性观察研究
阴茎癌很罕见，数据也很少。塔塔医院（孟买）对 91 名患者进行的观察性研究。19例新辅助紫杉醇+铂类治疗患者中，ORR=37%，手术切除率=31.5%。71 名接受根治性治疗的患者的平均 OS 为 33.8 个月。在 20 名接受姑息化疗的患者中，ORR-20%，中位 OS=11.4 个月
京公网安备 11010802027423号